High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes

High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes

Purpose: Brachytherapy (BT) boost after radio-chemotherapy (RCT) is a standard of care in the management of locally advanced cervical cancer (LACC). As there is no consensus on high-dose-rate (HDR) BT fractionation schemes, our aim was to report the oncological outcome and toxicity profile of four d...

Full description

Bibliographic Details
Main Authors: Maud le Guyader, Daniel Lam Cham Kee, Brice Thamphya, Renaud Schiappa, Mathieu Gautier, Marie-Eve Chand-Fouche, Jean-Michel Hannoun-Levi
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Cervical cancer
Brachytherapy
High-dose-rate
Fractionation scheme
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630821000902

Internet

http://www.sciencedirect.com/science/article/pii/S2405630821000902

Similar Items